SequelSEC

BALCHEM CORP BCPC

Chemicals & Allied Products · CIK 0000009326 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$284.00M
Fiscal year ended 2026-06-30
Operating income
$59.22M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

BALCHEM CORP (BCPC) reported revenue of $284.00M and net income of $44.62M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from BALCHEM CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Chemicals & Allied Products.

Income

BALCHEM CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$284.00M$270.71M$263.62M$267.56M$255.47M$250.52M$240.00M$239.94M$234.08M$239.66M
Cost of revenue$180.31M$169.62M$169.72M$172.10M$162.35M$162.35M$153.67M$154.58M$151.09M$158.14M
Gross profit$103.68M$101.08M$93.90M$95.45M$93.11M$88.17M$86.34M$85.36M$82.99M$81.51M
Operating income$59.22M$55.63M$52.29M$54.58M$51.44M$51.02M$47.44M$47.99M$45.80M$41.68M
Net income$44.62M$40.28M$39.22M$40.29M$38.28M$37.05M$33.58M$33.84M$32.07M$28.99M
Research & development$4.53M$5.88M$5.05M$4.50M$4.30M$4.66M$4.51M$4.33M$3.85M$4.10M
Weighted-average diluted sharesshares 32.20Mshares 32.28MUnavailableshares 32.60Mshares 32.68Mshares 32.81MUnavailableshares 32.78Mshares 32.65Mshares 32.63M
Pretax income$57.78M$52.52M$50.04M$52.04M$49.01M$47.94M$44.48M$43.89M$41.23M$36.85M
Income tax expense$13.17M$12.24M$10.81M$11.76M$10.73M$10.89M$10.90M$10.06M$9.16M$7.86M
Diluted EPS$1.39$1.25$1.21$1.24$1.17$1.13$1.03$1.03$0.98$0.89
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$18.79M$18.48M$16.50M$17.29M$18.07M$15.56M$17.26M$17.48M$15.33M$17.51M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

BALCHEM CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$63.17M$72.87M$74.57M$65.09M$65.43M$49.90M$49.52M$73.69M$63.74M$60.35M
Total assets$1.69B$1.69B$1.69B$1.66B$1.68B$1.62B$1.58B$1.60B$1.57B$1.59B
Current assets$388.42M$388.94M$365.61M$343.72M$364.86M$340.24M$313.77M$325.99M$320.16M$324.86M
Total liabilities$384.63M$408.63M$428.84M$363.17M$410.33M$408.85M$425.46M$419.72M$462.60M$509.91M
Current liabilities$145.76M$152.54M$176.38M$126.37M$138.14M$139.56M$157.68M$109.44M$113.32M$124.42M
Total equity incl. NCI$1.30B$1.29B$1.26B$1.30B$1.27B$1.21B$1.15B$1.18B$1.11B$1.08B
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$161.55M$146.74M$131.45M$132.44M$148.15M$144.93M$130.80M$118.51M$117.10M$110.38M
Accounts receivable$148.97M$154.23M$143.60M$131.54M$135.98M$130.45M$119.66M$120.54M$123.40M$139.88M
Goodwill$808.81M$811.45M$816.38M$816.49M$816.39M$793.09M$780.03M$781.11M$770.03M$771.54M
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

BALCHEM CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow$46.71M$40.06M$67.28M$65.57M$47.25M$36.46M$52.32M$51.30M$44.99M$33.39M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$10.93M-$6.29M-$16.42M-$14.94M-$6.62M-$5.91M-$36.96M-$9.18M-$6.86M-$6.74M
Financing cash flow-$44.83M-$34.78M-$41.25M-$50.83M-$28.76M-$31.97M-$35.21M-$34.39M-$34.19M-$30.02M
Net change in cash-$9.70M-$1.70M$9.48M-$334.00K$15.53M$386.00K-$24.18M$9.96M$3.39M-$4.10M
Stock-based compensation$5.92M$5.36M$3.76M$4.65M$5.84M$3.81M$3.89M$4.15M$3.89M$4.75M
Common dividends paid$3.00K$30.77M$11.00K$11.00K$2.00K$28.26M$4.00K$4.00K$13.00K$25.56M
Common share repurchases$28.79M$15.69M$53.63M$15.42M$33.26M$5.32M$306.00K$163.00K$11.00K$5.20M
Depreciation & amortization$12.22M$12.49M$11.72M$11.55M$11.40M$11.01M$10.90M$10.90M$12.51M$13.67M

Derived

BALCHEM CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin36.5%37.3%35.6%35.7%36.4%35.2%36.0%35.6%35.5%34.0%
Operating margin20.9%20.5%19.8%Unavailable20.1%20.4%19.8%UnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue2.1%2.0%1.4%Unavailable2.3%1.5%1.6%UnavailableUnavailableUnavailable
Current ratio2.66x2.55x2.07x2.72x2.64x2.44x1.99x2.98x2.83x2.61x
Revenue YoY growth11.2%8.1%9.8%11.5%9.1%4.5%4.9%4.3%1.2%3.1%
Net margin15.7%Unavailable14.9%15.1%15.0%Unavailable14.0%14.1%13.7%12.1%
R&D / revenue1.6%2.2%1.9%Unavailable1.7%1.9%1.9%UnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate22.8%23.3%21.6%Unavailable21.9%22.7%24.5%UnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BCPC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-20View SEC filing
10-Q · Filed 2025-10-21View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-04-24View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.